IP Verse

An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis - EP4041186B1

PatentPatent Analysis

EP4041186

LEO PHARMA
Application Number
EP20789063A
Filing Date
Oct 7, 2020
Status
Granted And Under Opposition
Apr 19, 2024
Grant Date
May 22, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3405197B1
EP3146969B1
EP2558435B1

Bibliography

The patent EP4041186B1 was granted to LEO Pharma on May 22, 2024 following the initial filing on Oct 7, 2020 under the application number EP20789063A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFFeb 24, 2025ADMISSIBLE
GENERICS UKFeb 21, 2025ADMISSIBLE
DR SCHONFeb 17, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents